Table 3a.
Baseline: mean (SD) (N = 52) | Post-study: mean (SD) (N = 44)a | |
---|---|---|
No unintended consequences of incentives | 4.29 (0.57) | 4.33 (0.51) |
Clinical relevance of quality targets | 4.11 (0.67) | 4.07 (0.53) |
Awareness and understanding of incentive program | 3. 97 (0.57) | 3. 61 (0.61)* |
Control over resources needed to achieve quality targets | 3.59 (0.65) | 3.66 (0.51) |
Salience of financial incentives | 3.45 (0.92) | 3.57 (0.78) |
Ability to secure cooperation of other staff | 3.05 (0.74) | 2.94 (0.73) |
Impact on clinical practice | 2.75 (0.54) | 2.27 (0.65)* |
Scale ranges from 1 to 7.
N = 36 for no unintended consequences, control, and financial salience.
P < 0.01 between pre- and post-study, paired sample t-test.